AARON DRAPEAU: Open Payments
NPI 1780152959 · KAILUA KONA, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$256 in 12 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $256
Food & beverage: $256
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $43 |
| Novo Nordisk Inc | 2 | $39 |
| PFIZER INC. | 1 | $28 |
| Boston Scientific Corporation | 1 | $27 |
| ABBVIE INC. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Amgen Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Verona Pharma, Inc. | 1 | $14 |
Products named: NUCALA, NURTEC ODT, WATCHMAN FLX, UBRELVY, XIFAXAN, EVENITY, Dexcom G6 Transmitter, WINREVAIR.
Industry payments across HI — which companies pay providers there.
